Is Pregnancy Protective from Rebound After Fingolimod Cessation? (PubMed, Clin Med Res) - Oct 24, 2026 - "She was managed acutely with intravenous methylprednisolone and rituximab. Following high-potency treatment, the patient demonstrated clinical improvement and maintained a stable postpartum course. This case highlights the complexities of managing MS during pregnancy and underscores the need for individualized therapeutic strategies, structured preconception counseling, and careful planning of DMT discontinuation to prevent severe rebound and optimize both maternal and fetal outcomes."
Journal • CNS Disorders • Multiple Sclerosis
|
|
Abdulaziz M Alqarni; Erum Shariff; Esra O Alakloby; Fahad A AlDamigh; Foziah J Alshamrani
|